Structure

Physi-Chem Properties

Molecular Weight:  438.17
Volume:  438.614
LogP:  5.241
LogD:  3.254
LogS:  -4.084
# Rotatable Bonds:  1
TPSA:  120.36
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.431
Synthetic Accessibility Score:  3.97
Fsp3:  0.4
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.9
MDCK Permeability:  1.4142262443783693e-05
Pgp-inhibitor:  0.017
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.019
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.009

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.008
Plasma Protein Binding (PPB):  98.51386260986328%
Volume Distribution (VD):  0.518
Pgp-substrate:  3.617213726043701%

ADMET: Metabolism

CYP1A2-inhibitor:  0.775
CYP1A2-substrate:  0.552
CYP2C19-inhibitor:  0.521
CYP2C19-substrate:  0.058
CYP2C9-inhibitor:  0.664
CYP2C9-substrate:  0.884
CYP2D6-inhibitor:  0.549
CYP2D6-substrate:  0.254
CYP3A4-inhibitor:  0.311
CYP3A4-substrate:  0.132

ADMET: Excretion

Clearance (CL):  5.729
Half-life (T1/2):  0.494

ADMET: Toxicity

hERG Blockers:  0.01
Human Hepatotoxicity (H-HT):  0.173
Drug-inuced Liver Injury (DILI):  0.96
AMES Toxicity:  0.435
Rat Oral Acute Toxicity:  0.142
Maximum Recommended Daily Dose:  0.743
Skin Sensitization:  0.855
Carcinogencity:  0.067
Eye Corrosion:  0.003
Eye Irritation:  0.862
Respiratory Toxicity:  0.647

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476306

Natural Product ID:  NPC476306
Common Name*:   Ugonin N
IUPAC Name:   2-[(8aR,10aS)-4-hydroxy-8,8,10a-trimethyl-6,7,8a,9-tetrahydro-5H-xanthen-1-yl]-3,5,7-trihydroxychromen-4-one
Synonyms:   Ugonin N
Standard InCHIKey:  RQGIPLQXOXXTRU-CJAUYULYSA-N
Standard InCHI:  InChI=1S/C25H26O7/c1-24(2)7-4-8-25(3)18(24)11-14-13(5-6-15(27)22(14)32-25)23-21(30)20(29)19-16(28)9-12(26)10-17(19)31-23/h5-6,9-10,18,26-28,30H,4,7-8,11H2,1-3H3/t18-,25+/m1/s1
SMILES:  CC1(CCCC2(C1CC3=C(C=CC(=C3O2)O)C4=C(C(=O)C5=C(C=C(C=C5O4)O)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL563382
PubChem CID:   44233937
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones
          • [CHEMONTID:0003587] 2'-prenylated flavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota rhizomes n.a. n.a. PMID[19583252]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota Rhizomes n.a. n.a. PMID[28169537]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11959 Helminthostachys zeylanica Species Ophioglossaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 10000.0 nM PMID[558832]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 10000.0 nM PMID[558832]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[558832]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476306 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.962 High Similarity NPC206605
0.956 High Similarity NPC12461
0.9557 High Similarity NPC472906
0.9497 High Similarity NPC78332
0.9494 High Similarity NPC476280
0.943 High Similarity NPC280680
0.943 High Similarity NPC46736
0.9371 High Similarity NPC471973
0.9371 High Similarity NPC297212
0.9321 High Similarity NPC472449
0.9317 High Similarity NPC186686
0.9317 High Similarity NPC189473
0.9317 High Similarity NPC23298
0.9313 High Similarity NPC234644
0.9308 High Similarity NPC235448
0.9308 High Similarity NPC197856
0.9304 High Similarity NPC3980
0.9259 High Similarity NPC275780
0.9259 High Similarity NPC472450
0.9259 High Similarity NPC239752
0.9255 High Similarity NPC474150
0.9255 High Similarity NPC474162
0.925 High Similarity NPC474960
0.925 High Similarity NPC139036
0.925 High Similarity NPC188433
0.9245 High Similarity NPC136674
0.9245 High Similarity NPC273843
0.9207 High Similarity NPC188079
0.9207 High Similarity NPC165456
0.9207 High Similarity NPC476637
0.9202 High Similarity NPC43319
0.9202 High Similarity NPC39091
0.9202 High Similarity NPC37870
0.9198 High Similarity NPC303460
0.9198 High Similarity NPC476295
0.9198 High Similarity NPC306321
0.9198 High Similarity NPC472625
0.9198 High Similarity NPC220313
0.9193 High Similarity NPC57715
0.9187 High Similarity NPC474290
0.9182 High Similarity NPC13779
0.9182 High Similarity NPC472907
0.9182 High Similarity NPC475799
0.9182 High Similarity NPC471985
0.9177 High Similarity NPC472905
0.9152 High Similarity NPC101107
0.9146 High Similarity NPC150131
0.9146 High Similarity NPC218226
0.9141 High Similarity NPC62261
0.9141 High Similarity NPC156432
0.9141 High Similarity NPC293319
0.9136 High Similarity NPC25152
0.9136 High Similarity NPC229632
0.9136 High Similarity NPC329760
0.913 High Similarity NPC80375
0.913 High Similarity NPC204290
0.913 High Similarity NPC200746
0.913 High Similarity NPC192686
0.913 High Similarity NPC118256
0.913 High Similarity NPC235018
0.913 High Similarity NPC36217
0.913 High Similarity NPC119209
0.913 High Similarity NPC45146
0.9125 High Similarity NPC218313
0.9125 High Similarity NPC474681
0.9125 High Similarity NPC237418
0.9125 High Similarity NPC67876
0.9125 High Similarity NPC187745
0.9125 High Similarity NPC161960
0.9125 High Similarity NPC304008
0.9125 High Similarity NPC472963
0.9119 High Similarity NPC56786
0.9119 High Similarity NPC80534
0.9114 High Similarity NPC37684
0.9114 High Similarity NPC157784
0.9114 High Similarity NPC63187
0.9096 High Similarity NPC4200
0.9091 High Similarity NPC288813
0.9091 High Similarity NPC475805
0.9085 High Similarity NPC477517
0.9085 High Similarity NPC272502
0.908 High Similarity NPC152659
0.908 High Similarity NPC207690
0.908 High Similarity NPC146134
0.908 High Similarity NPC236521
0.908 High Similarity NPC248638
0.9074 High Similarity NPC167678
0.9074 High Similarity NPC29876
0.9074 High Similarity NPC474038
0.9074 High Similarity NPC32694
0.9074 High Similarity NPC173137
0.9074 High Similarity NPC61010
0.9068 High Similarity NPC204879
0.9068 High Similarity NPC476242
0.9068 High Similarity NPC55738
0.9068 High Similarity NPC100123
0.9062 High Similarity NPC6633
0.9062 High Similarity NPC274730
0.9062 High Similarity NPC133970
0.9062 High Similarity NPC5322
0.9062 High Similarity NPC115853
0.9062 High Similarity NPC24640
0.9057 High Similarity NPC170492
0.9057 High Similarity NPC236223
0.9057 High Similarity NPC78326
0.9057 High Similarity NPC179126
0.9057 High Similarity NPC270620
0.9051 High Similarity NPC205046
0.9051 High Similarity NPC59162
0.9051 High Similarity NPC125062
0.9051 High Similarity NPC200740
0.9051 High Similarity NPC54394
0.9051 High Similarity NPC304295
0.9051 High Similarity NPC252933
0.9036 High Similarity NPC279209
0.9036 High Similarity NPC102277
0.903 High Similarity NPC126204
0.9024 High Similarity NPC224280
0.9024 High Similarity NPC125039
0.9024 High Similarity NPC7154
0.9024 High Similarity NPC72787
0.9024 High Similarity NPC58223
0.9024 High Similarity NPC36
0.9024 High Similarity NPC475888
0.9024 High Similarity NPC36916
0.9024 High Similarity NPC303174
0.9024 High Similarity NPC7688
0.9018 High Similarity NPC211107
0.9018 High Similarity NPC83922
0.9018 High Similarity NPC472964
0.9018 High Similarity NPC472448
0.9018 High Similarity NPC201800
0.9012 High Similarity NPC470183
0.9012 High Similarity NPC14353
0.9012 High Similarity NPC228785
0.9012 High Similarity NPC472902
0.9012 High Similarity NPC282009
0.9012 High Similarity NPC320359
0.9012 High Similarity NPC56085
0.9012 High Similarity NPC287328
0.9012 High Similarity NPC475784
0.9006 High Similarity NPC471479
0.9006 High Similarity NPC219867
0.9006 High Similarity NPC299520
0.9006 High Similarity NPC471515
0.9006 High Similarity NPC476170
0.9006 High Similarity NPC180011
0.9006 High Similarity NPC27337
0.9006 High Similarity NPC241904
0.9006 High Similarity NPC473272
0.9006 High Similarity NPC52889
0.9006 High Similarity NPC111969
0.9006 High Similarity NPC284820
0.9006 High Similarity NPC300727
0.9006 High Similarity NPC129684
0.9 High Similarity NPC234255
0.9 High Similarity NPC133392
0.9 High Similarity NPC200246
0.9 High Similarity NPC472280
0.9 High Similarity NPC67396
0.8994 High Similarity NPC237994
0.8994 High Similarity NPC260979
0.8994 High Similarity NPC279989
0.8994 High Similarity NPC472912
0.8994 High Similarity NPC55205
0.8994 High Similarity NPC471982
0.8994 High Similarity NPC82325
0.8987 High Similarity NPC88804
0.8987 High Similarity NPC50728
0.8987 High Similarity NPC151473
0.8987 High Similarity NPC3825
0.8987 High Similarity NPC166753
0.8976 High Similarity NPC177480
0.8976 High Similarity NPC107627
0.8976 High Similarity NPC300307
0.897 High Similarity NPC120593
0.897 High Similarity NPC471213
0.8963 High Similarity NPC474240
0.8963 High Similarity NPC41301
0.8963 High Similarity NPC319200
0.8963 High Similarity NPC187491
0.8957 High Similarity NPC472632
0.8957 High Similarity NPC472275
0.8957 High Similarity NPC278052
0.8957 High Similarity NPC278427
0.8957 High Similarity NPC84324
0.8957 High Similarity NPC40491
0.8957 High Similarity NPC471499
0.8957 High Similarity NPC165970
0.8957 High Similarity NPC187354
0.8957 High Similarity NPC471210
0.8957 High Similarity NPC288131
0.8957 High Similarity NPC305987
0.8957 High Similarity NPC289771
0.8957 High Similarity NPC259456
0.8957 High Similarity NPC26326
0.8957 High Similarity NPC66618
0.8957 High Similarity NPC113163
0.8951 High Similarity NPC74178
0.8951 High Similarity NPC210459

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476306 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9024 High Similarity NPD6167 Clinical (unspecified phase)
0.9024 High Similarity NPD6168 Clinical (unspecified phase)
0.9024 High Similarity NPD6166 Phase 2
0.8875 High Similarity NPD1934 Approved
0.8854 High Similarity NPD1512 Approved
0.882 High Similarity NPD2801 Approved
0.882 High Similarity NPD2393 Clinical (unspecified phase)
0.8726 High Similarity NPD1511 Approved
0.8598 High Similarity NPD3882 Suspended
0.8553 High Similarity NPD4378 Clinical (unspecified phase)
0.8538 High Similarity NPD6797 Phase 2
0.8537 High Similarity NPD3817 Phase 2
0.8529 High Similarity NPD7054 Approved
0.8488 Intermediate Similarity NPD7251 Discontinued
0.848 Intermediate Similarity NPD7472 Approved
0.848 Intermediate Similarity NPD7074 Phase 3
0.8439 Intermediate Similarity NPD7808 Phase 3
0.8412 Intermediate Similarity NPD7473 Discontinued
0.8343 Intermediate Similarity NPD6232 Discontinued
0.8333 Intermediate Similarity NPD5494 Approved
0.8333 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD4380 Phase 2
0.8284 Intermediate Similarity NPD6959 Discontinued
0.8263 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8256 Intermediate Similarity NPD3818 Discontinued
0.8253 Intermediate Similarity NPD1465 Phase 2
0.8214 Intermediate Similarity NPD7075 Discontinued
0.8208 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8208 Intermediate Similarity NPD5844 Phase 1
0.8204 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7819 Suspended
0.8114 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6599 Discontinued
0.8 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3749 Approved
0.8 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD6801 Discontinued
0.7963 Intermediate Similarity NPD3750 Approved
0.795 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD1549 Phase 2
0.7937 Intermediate Similarity NPD6099 Approved
0.7937 Intermediate Similarity NPD6100 Approved
0.7927 Intermediate Similarity NPD6799 Approved
0.7917 Intermediate Similarity NPD7411 Suspended
0.7875 Intermediate Similarity NPD1510 Phase 2
0.7841 Intermediate Similarity NPD3751 Discontinued
0.7829 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD2796 Approved
0.7816 Intermediate Similarity NPD3787 Discontinued
0.7791 Intermediate Similarity NPD2800 Approved
0.779 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD5402 Approved
0.7772 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD3926 Phase 2
0.7764 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD1247 Approved
0.7746 Intermediate Similarity NPD919 Approved
0.7736 Intermediate Similarity NPD1240 Approved
0.7736 Intermediate Similarity NPD943 Approved
0.7711 Intermediate Similarity NPD7390 Discontinued
0.7707 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD5403 Approved
0.7663 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7657 Intermediate Similarity NPD7199 Phase 2
0.7654 Intermediate Similarity NPD3748 Approved
0.7644 Intermediate Similarity NPD6234 Discontinued
0.7643 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1607 Approved
0.764 Intermediate Similarity NPD7228 Approved
0.7636 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7768 Phase 2
0.7588 Intermediate Similarity NPD3226 Approved
0.7569 Intermediate Similarity NPD6559 Discontinued
0.756 Intermediate Similarity NPD2532 Approved
0.756 Intermediate Similarity NPD5401 Approved
0.756 Intermediate Similarity NPD2533 Approved
0.756 Intermediate Similarity NPD2534 Approved
0.7554 Intermediate Similarity NPD8150 Discontinued
0.7546 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1613 Approved
0.7516 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD6777 Approved
0.7487 Intermediate Similarity NPD6779 Approved
0.7487 Intermediate Similarity NPD6782 Approved
0.7487 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD6778 Approved
0.7487 Intermediate Similarity NPD6780 Approved
0.7487 Intermediate Similarity NPD6781 Approved
0.7487 Intermediate Similarity NPD6776 Approved
0.7486 Intermediate Similarity NPD8313 Approved
0.7486 Intermediate Similarity NPD8312 Approved
0.7471 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD8434 Phase 2
0.7457 Intermediate Similarity NPD37 Approved
0.7455 Intermediate Similarity NPD2346 Discontinued
0.7429 Intermediate Similarity NPD4965 Approved
0.7429 Intermediate Similarity NPD4966 Approved
0.7429 Intermediate Similarity NPD4967 Phase 2
0.7425 Intermediate Similarity NPD4628 Phase 3
0.7423 Intermediate Similarity NPD6651 Approved
0.7394 Intermediate Similarity NPD2935 Discontinued
0.7391 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD4908 Phase 1
0.7371 Intermediate Similarity NPD7435 Discontinued
0.7365 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD447 Suspended
0.7358 Intermediate Similarity NPD2494 Approved
0.7358 Intermediate Similarity NPD2493 Approved
0.7353 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4582 Approved
0.7333 Intermediate Similarity NPD4583 Approved
0.7333 Intermediate Similarity NPD2799 Discontinued
0.7329 Intermediate Similarity NPD3027 Phase 3
0.7329 Intermediate Similarity NPD4625 Phase 3
0.7294 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7458 Discontinued
0.7283 Intermediate Similarity NPD7685 Pre-registration
0.7282 Intermediate Similarity NPD7697 Approved
0.7282 Intermediate Similarity NPD7696 Phase 3
0.7282 Intermediate Similarity NPD4002 Approved
0.7282 Intermediate Similarity NPD7698 Approved
0.7282 Intermediate Similarity NPD4004 Approved
0.7278 Intermediate Similarity NPD6190 Approved
0.7268 Intermediate Similarity NPD3450 Approved
0.7268 Intermediate Similarity NPD3452 Approved
0.7262 Intermediate Similarity NPD1243 Approved
0.7256 Intermediate Similarity NPD230 Phase 1
0.7249 Intermediate Similarity NPD2488 Approved
0.7249 Intermediate Similarity NPD2490 Approved
0.7246 Intermediate Similarity NPD2344 Approved
0.7245 Intermediate Similarity NPD7870 Phase 2
0.7245 Intermediate Similarity NPD7871 Phase 2
0.724 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD3300 Phase 2
0.7225 Intermediate Similarity NPD6534 Approved
0.7225 Intermediate Similarity NPD6535 Approved
0.7225 Intermediate Similarity NPD4363 Phase 3
0.7225 Intermediate Similarity NPD4360 Phase 2
0.7222 Intermediate Similarity NPD7095 Approved
0.7222 Intermediate Similarity NPD7701 Phase 2
0.7219 Intermediate Similarity NPD7003 Approved
0.7219 Intermediate Similarity NPD8166 Discontinued
0.7206 Intermediate Similarity NPD4111 Phase 1
0.7206 Intermediate Similarity NPD4665 Approved
0.7204 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7801 Approved
0.7195 Intermediate Similarity NPD4060 Phase 1
0.7189 Intermediate Similarity NPD7240 Approved
0.7186 Intermediate Similarity NPD8151 Discontinued
0.7186 Intermediate Similarity NPD1551 Phase 2
0.7184 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD2313 Discontinued
0.7178 Intermediate Similarity NPD3268 Approved
0.7178 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD920 Approved
0.7167 Intermediate Similarity NPD8127 Discontinued
0.7152 Intermediate Similarity NPD1201 Approved
0.7152 Intermediate Similarity NPD1933 Approved
0.7151 Intermediate Similarity NPD7549 Discontinued
0.715 Intermediate Similarity NPD2974 Approved
0.715 Intermediate Similarity NPD2973 Approved
0.715 Intermediate Similarity NPD2975 Approved
0.715 Intermediate Similarity NPD7874 Approved
0.715 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2403 Approved
0.7143 Intermediate Similarity NPD2798 Approved
0.7136 Intermediate Similarity NPD7907 Approved
0.7128 Intermediate Similarity NPD4580 Approved
0.7127 Intermediate Similarity NPD5710 Approved
0.7127 Intermediate Similarity NPD7229 Phase 3
0.7127 Intermediate Similarity NPD5711 Approved
0.7126 Intermediate Similarity NPD1653 Approved
0.7114 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD7783 Phase 2
0.7113 Intermediate Similarity NPD7699 Phase 2
0.7113 Intermediate Similarity NPD7700 Phase 2
0.711 Intermediate Similarity NPD6273 Approved
0.7105 Intermediate Similarity NPD4287 Approved
0.7083 Intermediate Similarity NPD5405 Approved
0.7083 Intermediate Similarity NPD5404 Approved
0.7083 Intermediate Similarity NPD5408 Approved
0.7083 Intermediate Similarity NPD5406 Approved
0.7081 Intermediate Similarity NPD1470 Approved
0.7081 Intermediate Similarity NPD2797 Approved
0.7079 Intermediate Similarity NPD4288 Approved
0.7076 Intermediate Similarity NPD2309 Approved
0.7073 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD8320 Phase 1
0.7071 Intermediate Similarity NPD8319 Approved
0.7063 Intermediate Similarity NPD4749 Approved
0.7063 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD6823 Phase 2
0.7052 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1610 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data